Previous close | 117.39 |
Open | 117.39 |
Bid | 0.00 x 1000 |
Ask | 0.00 x 1100 |
Day's range | 116.50 - 117.73 |
52-week range | 96.92 - 132.77 |
Volume | |
Avg. volume | 8,341,582 |
Market cap | 322.648B |
Beta (5Y monthly) | 1.02 |
PE ratio (TTM) | 30.78 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.60 (1.37%) |
Ex-dividend date | 09 Apr 2024 |
1y target est | N/A |
Insights into First Eagle's Latest 13F Filing and Its Impact on Portfolio Dynamics
(Bloomberg) -- When Oracle Corp. spent $28 billion two years ago to acquire electronic-records company Cerner Corp., it promised a revolution in health care technology. Most Read from Bloomberg‘Seriously Underwater’ Home Mortgages Tick Up Across the USApple Apologizes for iPad Pro Ad, Scraps Plan to Air It on TVMarjorie Taylor Greene Finally Got What She Deserved: DefeatMicrosoft’s Xbox Is Planning More Cuts After Studio ClosingsCo-founder and Chairman Larry Ellison declared the deal would help
Recently, Zacks.com users have been paying close attention to Oracle (ORCL). This makes it worthwhile to examine what the stock has in store.